Madrigal Pharmaceuticals Director Friedman Paul A Sells Shares, Buys 26,176 Shares

Madrigal Pharmaceuticals, Inc. (MDGL) has announced a series of transactions involving the sale and purchase of shares by its directors. Friedman Paul A, a director of the company, sold 700 shares at $351.57/share on July 17, 2025, and purchased 26,176 shares at $9.45/share on July 16, 2025. Friedman also sold 5,541 shares at $350.17/share, 2,371 shares at $351.38/share, 2,110 shares at $352.67/share, 2,319 shares at $353.82/share, 6,851 shares at $354.65/share, and 5,784 shares at $355.61/share on July 16, 2025. Additionally, Friedman purchased 2,700 shares at $9.45/share on July 17, 2025, and sold 2,000 shares at $350.1/share on the same day. Taub Rebecca, another director, purchased 2,657 shares at $9.45/share on July 17, 2025, and sold 2,569 shares at $353.82/share on July 16, 2025. Taub also sold 1,380 shares at $356.52/share, 1,897 shares at $351.37/share, and 600 shares at $351.5/share on July 16 and 17, 2025. Further, Taub sold 2,357 shares at $352.64/share, 2,057 shares at $350.09/share, and 5,800 shares at $354.61/share on July 16, 2025.